Meihao Medical Group Co. Ltd. provided preliminary unaudited consolidated group earnings guidance for the six months ended 30 June 2023. For the period, the Group expects to record a net loss ranging from approximately RMB 1.8 million to approximately RMB 2.3 million (for the six months ended 30 June 2022: net profit of RMB 10.9 million).

The expected loss was mainly attributed to overall decrease of gross profit due to the following reasons: number of visits decreased as a result of the increased number of infections due to the complete lifting of Covid-19 pandemic prevention measures and general downturn in consumer market; a decrease of revenue generated from implant dentistry as a result of the fact that patients are postponing implanting given the implementation of collective procurement dental implants policy since March 2023; and the fact that the Group is still committed to social responsibilities and maintained the existing number of employees and had no downsizing during the Relevant Period despite of the abovementioned.